August J. Moretti

2016 - DepoMed

In 2016, August J. Moretti earned a total compensation of $1.8M as Chief Financial Officer and Senior Vice President at DepoMed, a 21% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$183,042
Option Awards$591,491
Salary$418,820
Stock Awards$602,625
Other$9,481
Total$1,805,459

Moretti received $602.6K in stock awards, accounting for 33% of the total pay in 2016.

Moretti also received $183K in non-equity incentive plan, $591.5K in option awards, $418.8K in salary and $9.5K in other compensation.

Rankings

In 2016, August J. Moretti's compensation ranked 5,366th out of 14,075 executives tracked by ExecPay. In other words, Moretti earned more than 61.9% of executives.

ClassificationRankingPercentile
All
5,366
out of 14,075
62nd
Division
Manufacturing
1,924
out of 5,486
65th
Major group
Chemicals And Allied Products
611
out of 1,900
68th
Industry group
Drugs
456
out of 1,543
70th
Industry
Pharmaceutical Preparations
364
out of 1,173
69th
Source: SEC filing on July 14, 2017.

Moretti's colleagues

We found five more compensation records of executives who worked with August J. Moretti at DepoMed in 2016.

2016

James Schoeneck

DepoMed

Chief Executive Officer

2016

R Shively

DepoMed

Former Senior Vice President and Chief Commercial Officer

2016

Matthew Gosling

DepoMed

General Counsel

2016

Srinivas Rao

DepoMed

Chief Medical Officer

2016

Thadd Vargas

DepoMed

Senior Vice President, Business Development

News

You may also like